UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2

Neurology, 2010-09, Vol.75 (13), p.1189-1194

2010

Volltextzugriff (PDF)

Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1

Nature genetics, 1994-10, Vol.8 (2), p.136-140

1994

Volltextzugriff (PDF)

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

Neurology, 1994-05, Vol.44 (5), p.913-913

1994

Volltextzugriff (PDF)

parkin mutation analysis in clinic patients with early-onset Parkinson's disease

American journal of medical genetics. Part A, 2004-08, Vol.129A (1), p.44-50

2004

Volltextzugriff (PDF)

Identification of two new KCNA1 mutations in episodic ataxia/myokymia families

Human molecular genetics, 1995-09, Vol.4 (9), p.1671-1672

1995

Volltextzugriff (PDF)

Apomorphine infusional therapy in parkinson's disease: Clinical utility and lack of tolerance

Movement disorders, 1995-01, Vol.10 (1), p.37-43

1995

Volltextzugriff (PDF)

Peripheral pharmacokinetics of apomorphine in humans

Annals of neurology, 1989-08, Vol.26 (2), p.232-238

1989

Volltextzugriff (PDF)

Pharmacokinetics of apomorphine in Parkinson's disease

Journal of neural transmission. Supplementum, 1995, Vol.45, p.137

Gancher, S

1995

Volltextzugriff (PDF)

Parkinson's disease, CYP2D6 polymorphism, and age

Neurology, 2001-05, Vol.56 (10), p.1363-1370

2001

Volltextzugriff (PDF)

A gene for episodic ataxia/myokymia maps to chromosome 12p13

American journal of human genetics, 1994-10, Vol.55 (4), p.702-709

1994

Volltextzugriff (PDF)

Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS

Stroke (1970), 2021-06, Vol.52 (6), p.1995-2004

2021

Volltextzugriff (PDF)

Parkin mutation analysis in clinic patients with early-onset Parkinson's disease (Am J Med Genet 129A: 44-50, 2004)

American journal of medical genetics. Part A, 2005-11, Vol.139A (1), p.56-56

2005

Volltextzugriff (PDF)

Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients

Neurology, 1987-06, Vol.37 (6), p.940-940

1987

Volltextzugriff (PDF)

Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease

Clinical neuropharmacology, 1999, Vol.22 (1), p.1-4

1999

Volltextzugriff (PDF)

Absorption of apomorphine by various routes in parkinsonism

Movement disorders, 1991, Vol.6 (3), p.212-216

1991

Volltextzugriff (PDF)

Does an inhibitory action of levodopa contribute to motor fluctuations?

Neurology, 1988-10, Vol.38 (10), p.1553-1553

1988

Volltextzugriff (PDF)

A 10-year follow-up--genotypic analysis disproves phenotypic classification

Movement disorders, 1997-05, Vol.12 (3), p.472-472

1997

Volltextzugriff (PDF)

Time course of tolerance to apomorphine in parkinsonism

Clinical pharmacology and therapeutics, 1992-11, Vol.52 (5), p.504-510

1992

Volltextzugriff (PDF)

Apomorphine tolerance in Parkinson's disease : lack of a dose effect

Clinical neuropharmacology, 1996-02, Vol.19 (1), p.59-64

1996

Volltextzugriff (PDF)

The effect of nigral implantation on sensitization to dopamine agonists in 6-hydroxydopamine-lesioned rats

Neuroscience, 1997-08, Vol.79 (4), p.963-972

1997

Volltextzugriff (PDF)

A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections

Open forum infectious diseases, 2021-03, Vol.8 (3), p.ofab089-ofab089

2021

Volltextzugriff (PDF)

Fatigue in levodopa-naive subjects with Parkinson disease

Neurology, 2008-08, Vol.71 (7), p.481

2008

Volltextzugriff (PDF)

SCA2 may present as levodopa-responsive parkinsonism

Movement disorders, 2003-04, Vol.18 (4), p.425-429

2003

Volltextzugriff (PDF)

Predictors of deterioration in health-related quality of life in Parkinson's disease: Results from the DATATOP trial

Movement disorders, 2008-04, Vol.23 (5), p.653-659

2008

Volltextzugriff (PDF)

Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of Parkinsonism

The Journal of pharmacology and experimental therapeutics, 1995-01, Vol.272 (1), p.275

1995

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Englisch
(104)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(61)
Humans
(49)
Neurosciences & Neurology
(42)
Biological And Medical Sciences
(41)
Medical Sciences
(41)
Clinical Neurology
(37)
Male
(35)
Middle Aged
(31)
Female
(30)
Parkinson Disease - Drug Therapy
(29)
Aged
(28)
Pharmacology. Drug Treatments
(25)
Neuropharmacology
(22)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(18)
Neurology
(16)
Parkinson Disease - Physiopathology
(16)
Adult
(15)
Levodopa - Therapeutic Use
(15)
Neurosciences
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2

Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

parkin mutation analysis in clinic patients with early-onset Parkinson's disease

Identification of two new KCNA1 mutations in episodic ataxia/myokymia families

Apomorphine infusional therapy in parkinson's disease: Clinical utility and lack of tolerance

Peripheral pharmacokinetics of apomorphine in humans

Pharmacokinetics of apomorphine in Parkinson's disease

Parkinson's disease, CYP2D6 polymorphism, and age

A gene for episodic ataxia/myokymia maps to chromosome 12p13

Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS

Parkin mutation analysis in clinic patients with early-onset Parkinson's disease (Am J Med Genet 129A: 44-50, 2004)

Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients

Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease

Absorption of apomorphine by various routes in parkinsonism

Does an inhibitory action of levodopa contribute to motor fluctuations?

A 10-year follow-up--genotypic analysis disproves phenotypic classification

Time course of tolerance to apomorphine in parkinsonism

Apomorphine tolerance in Parkinson's disease : lack of a dose effect

The effect of nigral implantation on sensitization to dopamine agonists in 6-hydroxydopamine-lesioned rats

A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections

Fatigue in levodopa-naive subjects with Parkinson disease

SCA2 may present as levodopa-responsive parkinsonism

Predictors of deterioration in health-related quality of life in Parkinson's disease: Results from the DATATOP trial

Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of Parkinsonism

Suchergebnisse filtern